Evidence map›Paper›PMID 29937342›Full record

ArticleMolecular cell2018

Histone Methylation by SETD1A Protects Nascent DNA through the Nucleosome Chaperone Activity of FANCD2.

Martin R Higgs, Koichi Sato, John J Reynolds, Shabana Begum, Rachel Bayley, Amalia Goula, Audrey Vernet, Karissa L Paquin, David G Skalnik, Wataru Kobayashi and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular cell, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 113 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 3 countries.

Martin R HiggsLysine Methylation and DNA Damage Laboratory, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK. Electronic address: m.r.higgs@bham.ac.uk.
Koichi SatoDepartment of Electrical Engineering and Bioscience, Waseda University, Shinjuku, Tokyo 169-8050, Japan.
John J ReynoldsGenome Stability and Human Disease Laboratory, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK.
Shabana BegumLysine Methylation and DNA Damage Laboratory, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK.
Rachel BayleyLysine Methylation and DNA Damage Laboratory, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK.
Amalia GoulaLysine Methylation and DNA Damage Laboratory, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK.
Audrey VernetGenome Stability and Human Disease Laboratory, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK.
Karissa L PaquinDepartment of Cell and Molecular Biology, University of Rhode Island, Kingston, RI 02881, USA.
David G SkalnikBiology Department, School of Science, Indiana University-Purdue University Indianapolis, Indianapolis, IN 46202, USA.
Wataru KobayashiDepartment of Electrical Engineering and Bioscience, Waseda University, Shinjuku, Tokyo 169-8050, Japan.
Minoru TakataLaboratory of DNA Damage Signaling, Department of Late Effects Studies Radiation Biology Center, Kyoto University Yoshida konoe cho, Sakyo ku, Kyoto 606-8501, Japan.
Niall G HowlettDepartment of Cell and Molecular Biology, University of Rhode Island, Kingston, RI 02881, USA.
Hitoshi KurumizakaDepartment of Electrical Engineering and Bioscience, Waseda University, Shinjuku, Tokyo 169-8050, Japan.
Hiroshi KimuraCell Biology Center, Institute of Innovative Research, Tokyo Institute of Technology, Kanagawa Prefecture 226-8501, Japan.
Grant S StewartGenome Stability and Human Disease Laboratory, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK. Electronic address: g.s.stewart@bham.ac.uk.
University of Birmingham · GBWaseda University · JPUniversity of Rhode Island · USIndiana University – Purdue University Indianapolis · USKyoto University · JPTokyo Institute of Technology · JP

Funding

Cancer Research UK 13030Cancer Research UK C17183/A13030Cancer Research UK C17183/A23303Medical Research Council MR/M009882/1Medical Research Council MR/P009085/1
6 · The paper itself

Abstract

Components of the Fanconi anemia and homologous recombination pathways play a vital role in protecting newly replicated DNA from uncontrolled nucleolytic degradation, safeguarding genome stability. Here we report that histone methylation by the lysine methyltransferase SETD1A is crucial for protecting stalled replication forks from deleterious resection. Depletion of SETD1A sensitizes cells to replication stress and leads to uncontrolled DNA2-dependent resection of damaged replication forks. The ability of SETD1A to prevent degradation of these structures is mediated by its ability to catalyze methylation on Lys4 of histone H3 (H3K4) at replication forks, which enhances FANCD2-dependent histone chaperone activity. Suppressing H3K4 methylation or expression of a chaperone-defective FANCD2 mutant leads to loss of RAD51 nucleofilament stability and severe nucleolytic degradation of replication forks. Our work identifies epigenetic modification and histone mobility as critical regulatory mechanisms in maintaining genome stability by restraining nucleases from irreparably damaging stalled replication forks.

Indexed as

A549 CellsDNADNA ReplicationEpigenesis, GeneticFanconi Anemia Complementation Group D2 ProteinHeLa CellsHistone-Lysine N-MethyltransferaseHistonesHumansMethylationMolecular ChaperonesNucleosomesRad51 RecombinaseDNAFANCD2 protein, humanFanconi Anemia Complementation Group D2 ProteinHistone-Lysine N-MethyltransferaseHistonesMolecular ChaperonesNucleosomesRAD51 protein, humanRad51 RecombinaseSetd1A protein, humanBOD1LFANCD2histone methylationlysine methyltransferasereplication fork replicationreplication stressSETD1A

Identifiers

PMID29937342
PMCPMC6039718
OpenAlexW2809592012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.